[HTML][HTML] New research progress on 18F-FDG PET/CT radiomics for EGFR mutation prediction in lung adenocarcinoma: a review

X Ge, J Gao, R Niu, Y Shi, X Shao, Y Wang… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Lung cancer, the most frequently diagnosed cancer worldwide, is the leading cause of
cancer-associated deaths. In recent years, significant progress has been achieved in basic …

New research progress on 18F-FDG PET/CT radiomics for EGFR mutation prediction in lung adenocarcinoma: a review

X Ge, J Gao, R Niu, Y Shi, X Shao, Y Wang - Frontiers in Oncology, 2023 - europepmc.org
Lung cancer, the most frequently diagnosed cancer worldwide, is the leading cause of
cancer-associated deaths. In recent years, significant progress has been achieved in basic …

New research progress on 18F-FDG PET/CT radiomics for EGFR mutation prediction in lung adenocarcinoma: a review

X Ge, J Gao, R Niu, Y Shi, X Shao, Y Wang, X Shao - Frontiers in Oncology - frontiersin.org
Lung cancer, the most frequently diagnosed cancer worldwide, is the leading cause of
cancer-associated deaths. In recent years, significant progress has been achieved in basic …

New research progress on 18F-FDG PET/CT radiomics for EGFR mutation prediction in lung adenocarcinoma: a review

X Ge, J Gao, R Niu, Y Shi, X Shao… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Lung cancer, the most frequently diagnosed cancer worldwide, is the leading cause of
cancer-associated deaths. In recent years, significant progress has been achieved in basic …

New research progress on 18F-FDG PET/CT radiomics for EGFR mutation prediction in lung adenocarcinoma: a review.

X Ge, J Gao, R Niu, Y Shi, X Shao, Y Wang - Frontiers in Oncology, 2023 - europepmc.org
Lung cancer, the most frequently diagnosed cancer worldwide, is the leading cause of
cancer-associated deaths. In recent years, significant progress has been achieved in basic …